KYNPRAIM
Dead / Abandoned — Abandoned — express abandonment (as of 25 Feb 2025)
What this means for you
This application is over — abandoned 24 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98418337
- Mark type
- Stylized text
- Filed
- 23 Feb 2024
- Abandoned
- 24 Feb 2025
- Attorney of record
- Andrew D. Price & Paula E. Hopkins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
Owner
- Immunocore Limited, Oxfordshire, GB
Prosecution history
- 25 Feb 2025 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 25 Feb 2025 — ABANDONMENT - EXPRESS MAILED
- 24 Feb 2025 — TEAS EXPRESS ABANDONMENT RECEIVED
- 09 Dec 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Dec 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 07 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Sept 2024 — NON-FINAL ACTION E-MAILED
- 07 Sept 2024 — NON-FINAL ACTION WRITTEN
- 06 Sept 2024 — ASSIGNED TO EXAMINER
- 23 Feb 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Feb 2024 — NEW APPLICATION ENTERED